
Vesibojung (Becipvovir Diphosphate Malate)
183mg
Tablet · Prescription medication
Idong Pharmaceutical Co., Ltd.
Becivobir diphosphate maleate is an antiviral agent used in the treatment of chronic hepatitis B.
MFDS ingredient code M265751
Becivobir diphosphate maleate is a nucleotide analog antiviral that is used to inhibit viral replication in patients with chronic hepatitis B. This ingredient is converted into an active form within liver cells, interfering with viral DNA synthesis.
Becivobir diphosphate maleate is converted into an active metabolite in the body that inhibits the DNA polymerase of the hepatitis B virus. This prevents the virus from replicating its genetic material, reducing the spread of infection.
Approved uses differ by product. Check each product's information for its actual use.
Compared to other nucleotide analogs, Becivobir diphosphate maleate has a lower incidence of resistance and a relatively lower risk of hepatic toxicity. Additionally, it has excellent effects on improving liver function during treatment, making it suitable for chronic hepatitis B therapy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.